Video

Dr. Bander on PSMA breakthroughs in prostate cancer

Author(s):

Urology Times staff

“Our preclinical therapy models all show us that the combination of the 2 agents [alpha and beta particles] is substantially superior to either agent alone,” says Neil H. Bander, MD.

In this video, Neil H. Bander, MD, discusses PSMA therapeutic innovations for patients with prostate cancer and how they will change diagnosis and treatment. Bander is the Bernard & Josephine Chaus professor of urologic oncology at Weill Cornell Medicine, New York City, New York.

Related Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Wayne Kuang, MD, answers a question during a Zoom video interview
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
Business meeting | Image Credit: © Panumas - stock.adobe.com
Related Content
Conventional imaging may understage prostate cancer, new data suggest
January 3rd 2025

Conventional imaging may understage prostate cancer, new data suggest

Hannah Clarke
“However, it was informative to uncover such a high number of metastatic findings in a well-defined cohort of patients resembling the EMBARK trial population that was supposed to only include those without metastases," says Adrien Holzgreve, MD, MHA.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023

Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer

Urology Times staff
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
TLX250-CDx BLA resubmitted to FDA for kidney cancer
January 2nd 2025

TLX250-CDx BLA resubmitted to FDA for kidney cancer

Hannah Clarke
The BLA for TLX250-CDx was initially submitted to the FDA in June 2024.
Prostate Gland - (BPH) Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
December 26th 2024

Top 10 BPH articles and videos of 2024

Benjamin P. Saylor
As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.
PSMA-PET shows diagnostic accuracy in initial staging of prostate cancer
December 20th 2024

PSMA-PET shows diagnostic accuracy in initial staging of prostate cancer

Hannah Clarke
The investigators found a positive correlation between PSA levels and SUVmax.
Man Receiving Medical Scan for Prostate Cancer Diagnosis | Image Credit: © Mark Kostich - stock.adobe.com
December 18th 2024

Top 10 urologic imaging stories in 2024

Benjamin P. Saylor
As the year comes to a close, we revisit some of this year’s top content on next-generation imaging agents in urology.
© 2025 MJH Life Sciences

All rights reserved.